- Home
- LSCC vs BPMC Comparison
LSCC vs BPMC Comparison
Compare LSCC & BPMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSCC
- BPMC
- Stock Information
- Founded
- LSCC 1983
- BPMC 2008
- Country
- LSCC United States
- BPMC United States
- Employees
- LSCC N/A
- BPMC N/A
- Industry
- LSCC Semiconductors
- BPMC Biotechnology: Pharmaceutical Preparations
- Sector
- LSCC Technology
- BPMC Health Care
- Exchange
- LSCC Nasdaq
- BPMC Nasdaq
- Market Cap
- LSCC 6.8B
- BPMC 5.8B
- IPO Year
- LSCC 1989
- BPMC 2015
- Fundamental
- Price
- LSCC $50.26
- BPMC $128.34
- Analyst Decision
- LSCC Strong Buy
- BPMC Buy
- Analyst Count
- LSCC 12
- BPMC 20
- Target Price
- LSCC $63.58
- BPMC $127.82
- AVG Volume (30 Days)
- LSCC 2.2M
- BPMC 7.0M
- Earning Date
- LSCC 07-28-2025
- BPMC 07-31-2025
- Dividend Yield
- LSCC N/A
- BPMC N/A
- EPS Growth
- LSCC N/A
- BPMC N/A
- EPS
- LSCC 0.37
- BPMC N/A
- Revenue
- LSCC $488,736,000.00
- BPMC $562,121,000.00
- Revenue This Year
- LSCC $3.41
- BPMC $44.46
- Revenue Next Year
- LSCC $18.44
- BPMC $32.78
- P/E Ratio
- LSCC $132.45
- BPMC N/A
- Revenue Growth
- LSCC N/A
- BPMC 99.19
- 52 Week Low
- LSCC $34.69
- BPMC $73.04
- 52 Week High
- LSCC $70.55
- BPMC $128.45
- Technical
- Relative Strength Index (RSI)
- LSCC 47.11
- BPMC 74.82
- Support Level
- LSCC $49.15
- BPMC $128.06
- Resistance Level
- LSCC $52.09
- BPMC $128.32
- Average True Range (ATR)
- LSCC 1.84
- BPMC 0.28
- MACD
- LSCC -0.04
- BPMC -1.17
- Stochastic Oscillator
- LSCC 30.20
- BPMC 59.68
About LSCC Lattice Semiconductor Corporation
Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.